{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1362262943971007232.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1097/rlu.0000000000001752"}},{"identifier":{"@type":"URI","@value":"https://journals.lww.com/10.1097/RLU.0000000000001752"}}],"dc:title":[{"@value":"Assessment of Organ Dosimetry for Planning Repeat Treatments of High-Dose 131I-MIBG Therapy"}],"dcterms:alternative":[{"@value":"123I-MIBG Versus Posttherapy 131I-MIBG Imaging"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1382262943971007233","@type":"Researcher","foaf:name":[{"@value":"Neeta Pandit-Taskar"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262943971007104","@type":"Researcher","foaf:name":[{"@value":"Pat Zanzonico"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262943971007234","@type":"Researcher","foaf:name":[{"@value":"Patrick Hilden"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262943971007235","@type":"Researcher","foaf:name":[{"@value":"Irina Ostrovnaya"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262943971007232","@type":"Researcher","foaf:name":[{"@value":"Jorge A. Carrasquillo"}]},{"@id":"https://cir.nii.ac.jp/crid/1382262943971007105","@type":"Researcher","foaf:name":[{"@value":"Shakeel Modak"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"03639762"}],"prism:publicationName":[{"@value":"Clinical Nuclear Medicine"}],"dc:publisher":[{"@value":"Ovid Technologies (Wolters Kluwer Health)"}],"prism:publicationDate":"2017-10","prism:volume":"42","prism:number":"10","prism:startingPage":"741","prism:endingPage":"748"},"reviewed":"false","url":[{"@id":"https://journals.lww.com/10.1097/RLU.0000000000001752"}],"createdAt":"2017-07-30","modifiedAt":"2021-05-14","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050302459014472448","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Radiation-Related Thyroid Cancer"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617881508352","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"High-dose 131I-mIBG as consolidation therapy in pediatric patients with relapsed neuroblastoma and ganglioneuroblastoma: the Japanese experience"}]},{"@id":"https://cir.nii.ac.jp/crid/1390568456337697408","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Radiological Technology for Targeted Radionuclide Therapy"},{"@language":"ja","@value":"核医学治療における放射線技術"},{"@language":"ja-Kana","@value":"カク イガク チリョウ ニ オケル ホウシャセン ギジュツ"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1097/rlu.0000000000001752"},{"@type":"CROSSREF","@value":"10.1210/endrev/bnad022_references_DOI_TrcpBnnWgklrJKrLQ2ffqs29amK"},{"@type":"CROSSREF","@value":"10.1007/s12149-020-01514-2_references_DOI_TrcpBnnWgklrJKrLQ2ffqs29amK"},{"@type":"CROSSREF","@value":"10.6009/jjrt.2020_jsrt_76.12.1237_references_DOI_TrcpBnnWgklrJKrLQ2ffqs29amK"}]}